½ÃÀ庸°í¼­
»óǰÄÚµå
1424466

½ÅÀå ½Å°æÂ÷´Ü µð¹ÙÀ̽º ½ÃÀå : ½Ã¼ú À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

Renal Denervation Devices Market, By Procedure Type, By End User, By Region

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ½ÅÀå ½Å°æÂ÷´Ü µð¹ÙÀ̽º ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 9¾ï 390¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç 2023-2030³âÀÇ CAGRÀº 14.5%·Î, 2030³â¿¡´Â 23¾ï 3,210¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

¸®Æ÷Æ® ´ë»ó ¹üÀ§ ¸®Æ÷Æ® »ó¼¼
±âÁسâ 2022³â 2023/2024³â ½ÃÀå ±Ô¸ð 9¾ï 390¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2018-2021³â ¿¹Ãø ±â°£ 2023-2030
¿¹Ãø ±â°£ 2023³â/2024-2030³â/2031³â CAGR : 14.50% 2030/2031³âÀÇ ¿¹ÃøÄ¡ 23¾ï 3,210¸¸ ´Þ·¯
µµÇ¥ 1. ¼¼°èÀÇ ½ÅÀå ½Å°æÂ÷´Ü µð¹ÙÀ̽º ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2023³â
Renal Denervation Devices Market-IMG1

½ÅÀå ½Å°æÂ÷´ÜÀº ½ÅÀå¿¡ ´ëÇÑ ±³°¨½Å°æ Ȱµ¿À» °¨¼Ò½ÃŰ´Â °ÍÀ» ¸ñÇ¥·Î ÇÏ´Â ÃÖ¼Ò Ä§½ÀÀû ½Ã¼úÀÔ´Ï´Ù. Ä«Å×Å͸¦ µ¿¸ÆÀ» ÅëÇØ ½ÅÀå¿¡ Ç÷¾×À» °ø±ÞÇÏ´Â ½ÅÀå µ¿¸Æ¿¡ µµ´ÞÇÏ°Ô ÇÕ´Ï´Ù. ±×¸®°í °íÇ÷¾ÐÀ» À¯¹ßÇÏ´Â ½ÅÈ£¸¦ ¹æÇØÇϱâ À§ÇØ Ç÷°üº®ÀÇ ½Å°æ¿¡ ¿¡³ÊÁö¸¦ °ø±ÞÇÕ´Ï´Ù. ¿¡³ÊÁö´Â °íÁÖÆÄ ÀýÁ¦, ÃÊÀ½ÆÄ, ÃÖ±Ù¿¡´Â È­ÇÐ ¹°ÁúÀÇ Á÷Á¢ ÁÖÀÔ ¹× °æÇÇÀû Àü´Þ ½Ã½ºÅÛÀ» ±â¹ÝÀ¸·Î ÇÑ »õ·Î¿î ¹æ¹ý µî ´Ù¾çÇÑ ¹æ¹ýÀ¸·Î ¿¡³ÊÁö¸¦ °ø±ÞÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÅÀå Å»¼öÀÇ ÀÌ·ÐÀû ±Ù°Å´Â ½ÅÀåÀÌ Ç÷¾Ð Á¶Àý¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù´Â ÀÌÇØ¿¡¼­ ºñ·ÔµË´Ï´Ù. ½ÅÀå ½Å°æÀÌ °úµµÇÏ°Ô È°¼ºÈ­µÇ¸é Àü½Å Ç÷¾ÐÀÌ »ó½ÂÇÏ°Ô µË´Ï´Ù. ÀÌ·¯ÇÑ °úȰ¼º ½Å°æ °æ·Î¸¦ Â÷´ÜÇÔÀ¸·Î½á ½ÅÀå ½Å°æÂ÷´ÜÀº ´Ù¸¥ Ä¡·á¹ýÀÌ È¿°ú°¡ ¾ø´Â »ç¶÷µéÀÇ Ç÷¾ÐÀ» Áö¼ÓÀûÀ¸·Î ³·Ãß´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ Ä¡·á¹ýÀº Ãʱâ ÀÓ»ó½ÃÇè¿¡¼­ À¯¸ÁÇÑ °á°ú¸¦ º¸¿´Áö¸¸, ÀÌÈÄ ÁøÇàµÈ ¿©·¯ ÀÓ»ó½ÃÇè¿¡¼­´Â °á°ú°¡ ¾ù°¥·È½À´Ï´Ù. ±×·³¿¡µµ ºÒ±¸Çϰí ÀÌ ÀÇ·á±â±â´Â °è¼Ó ¿¬±¸°³¹ßµÇ°í ÀÖÀ¸¸ç, ÇöÀçµµ ¾ÈÀü¼º°ú À¯È¿¼ºÀ» Æò°¡Çϱâ À§ÇÑ ÀÓ»ó½ÃÇèÀÌ ÁøÇà ÁßÀÔ´Ï´Ù.

½ÃÀå ¿ªÇÐ :

½ÅÀå ½Å°æÂ÷´Ü µð¹ÙÀ̽º ½ÃÀåÀº ¿¹Ãø ±â°£(2023-2030³â) µ¿¾È Å« ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÃÀå ¼ºÀå¿¡´Â °íÇ÷¾Ð À¯º´·ü Áõ°¡¿Í °°Àº ¸î °¡Áö ¿äÀÎÀÌ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Çõ½ÅÀûÀÎ Á¦Ç°ÀÇ ½ÂÀÎ Áõ°¡´Â ¿¹Ãø ±â°£ Áß ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¸é ÀÇ·á±â±â ±â¾÷ÀÎ Kalos MedicalÀº °íÇ÷¾Ð Ä¡·á¸¦ À§ÇÑ ½ÅÀå ½Å°æÂ÷´Ü ÀÇ·á±â±âÀÇ °³¹ßÀ» ÁøÇà½Ã۱â À§ÇØ 467¸¸ ¿ø(¾à 350¸¸ ´Þ·¯)ÀÇ º¸Á¶±ÝÀ» ¹Þ¾Ò½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • ÀÌ Á¶»ç ¸®Æ÷Æ®´Â ¼¼°èÀÇ ½ÅÀå ½Å°æÂ÷´Ü µð¹ÙÀ̽º ½ÃÀåÀ» »ó¼¼È÷ ºÐ¼®ÇÏ°í ½ÃÀå ±Ô¸ð(´ÜÀ§ : ¹é¸¸ ´Þ·¯), 2022³âÀ» ±âÁسâÀ¸·Î ÇÑ ¿¹Ãø ±â°£(2023-2030³â) CAGR µîÀ» Á¦°øÇÕ´Ï´Ù.
  • ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¸ÅÃâ ¼ºÀå ±âȸ¸¦ ¼³¸íÇϰí, ÀÌ ½ÃÀå¿¡ ´ëÇÑ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¿¡ ´ëÇØ ÇØ¼³Çϰí ÀÖ½À´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ Áß¿äÇÑ ÀλçÀÌÆ®µµ Á¦°øÇϰí ÀÖ½À´Ï´Ù.
  • ¼¼°èÀÇ ½ÅÀå ½Å°æÂ÷´Ü µð¹ÙÀ̽º ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À», ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ½ÇÀû, Àü·« µîÀÇ ÆÄ¶ó¹ÌÅÍ¿¡ ±â¹ÝÇÏ¿© ÇÁ·ÎÆÄÀϸµÇϰí ÀÖ½À´Ï´Ù.
  • º» Á¶»ç¿¡¼­ ´Ù·ç´Â ÁÖ¿ä ±â¾÷¿¡´Â Medtronic, Recor Medical, Inc., Boston Scientific Corp, Kona Medical, Terumo Corporation, Abbott, Ablative Solutions µîÀÌ Æ÷ÇԵ˴ϴÙ.
  • º» ¸®Æ÷Æ®·ÎºÎÅÍÀÇ ÀλçÀÌÆ®¿¡ ÀÇÇØ ±â¾÷ÀÇ ¸¶ÄÉÆÃ ´ã´çÀÚ ¹× °æ¿µÁøÀº ÇâÈÄ Á¦Ç° ¹ß¸Å, Á¦Ç° ¾÷±×·¹À̵å, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ °üÇÑ Á¤º¸¿¡ ±â¹ÝÇÑ ÀÇ»ç°áÁ¤À» ½ÃÇàÇÒ ¼ö ÀÖ°Ô µË´Ï´Ù.
  • ¼¼°èÀÇ ½ÅÀå ½Å°æÂ÷´Ü µð¹ÙÀ̽º ½ÃÀå ¸®Æ÷Æ®´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü¿©¾÷ü, À繫 ¾Ö³Î¸®½ºÆ® µî, ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î Çϰí ÀÖ½À´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚ´Â ¼¼°èÀÇ ½ÅÀå ½Å°æÂ÷´Ü µð¹ÙÀ̽º ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • ¸®Æ÷Æ® ¼³¸í
    • ½ÃÀåÀÇ Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ÃËÁø¿äÀÎ
  • ±Þ¼º ±¸È¹ÁõÈıºÀÇ À¯º´·ü Áõ°¡
  • ±â¼úÀÇ Áøº¸
    • ¾ïÁ¦¿äÀÎ
  • º¹ÀâÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
    • ±âȸ
  • ½ÅÈï ±¹°¡ °æÁ¦¿¡¼­ ¹Ì°³¹ßÀÇ °¡´É¼º
  • ¿µÇ⠺м®
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Ç°ÀÇ ¹ß¸Å/½ÂÀÎ
  • PEST ºÐ¼®
  • PorterÀÇ »ê¾÷ ºÐ¼®
  • ÇÕº´°ú Àμö ½Ã³ª¸®¿À

Á¦4Àå ¼¼°èÀÇ ½ÅÀå ½Å°æÂ÷´Ü µð¹ÙÀ̽º ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)ÀÇ ¿ªÇÐ
  • °ø±ÞÃø°ú ¼ö¿äÃø ºÐ¼®
  • °æÁ¦Àû ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ½ÅÀå ½Å°æÂ÷´Ü µð¹ÙÀ̽º ½ÃÀå, ½Ã¼ú À¯Çüº°, 2018-2030³â

  • °æÇÇÀû ½ÅÀå ½Å°æÂ÷´Ü
  • °íÁÖÆÄ ½ÅÀå ½Å°æÂ÷´Ü
  • ÃÊÀ½ÆÄ ½ÅÀå ½Å°æÂ÷´Ü
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ ½ÅÀå ½Å°æÂ÷´Ü µð¹ÙÀ̽º ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2018-2030³â

  • º´¿ø
  • Ŭ¸®´Ð
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ½ÅÀå ½Å°æÂ÷´Ü µð¹ÙÀ̽º ½ÃÀå, Áö¿ªº°, 2018-2030³â

  • ºÏ¹Ì
  • ¹Ì±¹
  • ij³ª´Ù
  • À¯·´
  • ¿µ±¹
  • µ¶ÀÏ
  • ÇÁ¶û½º
  • ÀÌÅ»¸®¾Æ
  • ½ºÆäÀÎ
  • ·¯½Ã¾Æ
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áß±¹
  • ÀϺ»
  • Àεµ
  • È£ÁÖ
  • ASEAN
  • Çѱ¹
  • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • ºê¶óÁú
  • ¾Æ¸£ÇîÆ¼³ª
  • ¸ß½ÃÄÚ
  • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿
  • GCC
  • À̽º¶ó¿¤
  • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
  • ³²¾ÆÇÁ¸®Ä«
  • Áß¾Ó¾ÆÇÁ¸®Ä«
  • ºÏ¾ÆÇÁ¸®Ä«

Á¦8Àå °æÀï ±¸µµ

  • Medtronic
  • Recor Medical, Inc.
  • Boston Scientific Corp
  • Kona Medical
  • Terumo Corporation
  • Abbott
  • Ablative Solutions
  • ±âŸ

Á¦9Àå ¼½¼Ç

  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç ¼Ò°³
KSA 24.02.27

The global renal denervation devices market size was valued at US$ 903.9 million in 2023 and is expected to reach US$ 2,332.1 million by 2030, at a CAGR of 14.5% from 2023 to 2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023/2024: US$ 903.9 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR: 14.50% 2030/2031 Value Projection: US$ 2,332.1 Mn
Figure 1. Global Renal Denervation Devices Market Share (%), by Region, 2023
Renal Denervation Devices Market - IMG1

Renal denervation is a minimally invasive procedure that aims to decrease the sympathetic nerve activity to the kidneys. It involves threading a catheter through the arteries until it reaches the renal arteries, which supplies blood to the kidneys. The device then delivers energy to the nerves in the vessel wall to disrupt the signals that can cause high blood pressure. The energy can be delivered through various methods, such as radiofrequency ablation, ultrasound, and more recently, direct injection of chemicals or new methodologies based on percutaneous delivery systems. The rationale behind renal denervation comes from the understanding that the kidneys play a significant role in blood pressure regulation. Overactive renal nerves can lead to increased systemic blood pressure. By disrupting these overactive nerve pathways, renal denervation can potentially help to sustainably lower blood pressure in people for whom other treatments have failed. Although the procedure showed promise in early clinical trials, some subsequent trials had mixed results, which led to further investigations to better understand the patient populations that may benefit and to optimize the technique. Nonetheless, the devices continue to be studied and developed, with ongoing clinical trials evaluating their safety and efficacy.

Market Dynamics:

The renal denervation devices market is expected to witness significant growth during the forecast period (2023-2030). Several factors contribute to the market growth including the rising prevalence of hypertension. Additionally, the increasing approval of innovative products is expected to propel the market growth over the forecast period. For instance, Kalos Medical, a medical device company, received a grant of Won4.67m (approximately $3.5m) to advance the development of its renal denervation medical device to treat hypertension.

Key Features of the Study:

  • This report provides an in-depth analysis of the global renal denervation devices market, including market size (in US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), with 2022 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • Key players in the global renal denervation devices market are profiled based on parameters such as company highlights, product portfolio, key highlights, financial performance, and strategies
  • Key companies covered in this study include Medtronic, Recor Medical, Inc., Boston Scientific Corp, Kona Medical, Terumo Corporation, Abbott, Ablative Solutions, and others
  • Insights from this report would enable marketers and management authorities of companies to make informed decisions regarding future product launches, product upgrades, market expansion, and marketing tactics.
  • The global renal denervation devices market report caters to various stakeholders in the industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global renal denervation devices market

Renal Denervation Devices Market Segmentation

  • By Procedure Type
    • Percutaneous Renal Denervation
    • Radiofrequency Renal Denervation
    • Ultrasound Renal Denervation
    • Others
  • By End User
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top Companies in the Renal Denervation Devices Market
    • Medtronic
    • Recor Medical, Inc
    • Boston Scientific Corp
    • Kona Medical
    • Terumo Corporation
    • Abbott
    • Ablative Solutions
    • Others

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Procedure Type
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing prevalence of acute compartment syndrome
  • Technological Advancement
    • Restraints
  • Complex Regulatory Framework
    • Opportunities
  • Untapped Potential in the Emerging Economies
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Renal Denervation Devices Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Renal Denervation Devices Market , By Procedure Type, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Percutaneous Renal Denervation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Radiofrequency Renal Denervation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Ultrasound Renal Denervation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Global Renal Denervation Devices Market , By End User, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)

7. Global Renal Denervation Devices Market, By Region, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2018 - 2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • China
  • Japan
  • India
  • Australia
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Region/Country, 2018-2030,(US$ Mn)
  • South Africa
  • Central Africa
  • North Africa

8. Competitive Landscape

  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Recor Medical, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Boston Scientific Corp
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Kona Medical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Terumo Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Ablative Solutions
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Others
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦